- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Novelix Pharmaceuticals Ltd (NOVE)
Novelix Pharmaceuticals Ltd stock price live, this page displays BO NOVE stock exchange data. View the NOVE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Novelix Pharmaceuticals Ltd real time stock price chart below.
What Is the Novelix Pharmaceuticals Ltd Stock Price Today?
The Novelix Pharmaceuticals Ltd stock price today is 70.95.
What Is the Stock Symbol for Novelix Pharmaceuticals Ltd?
The stock symbol for Novelix Pharmaceuticals Ltd is "NOVE."
What Stock Exchange Does Novelix Pharmaceuticals Ltd Trade On?
Novelix Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Novelix Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Novelix Pharmaceuticals Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOVE quote. (ISIN: INE314I01036)
What Is the Novelix Pharmaceuticals Ltd Stock Price Today?
The Novelix Pharmaceuticals Ltd stock price today is 70.95.
What Is the Stock Symbol for Novelix Pharmaceuticals Ltd?
The stock symbol for Novelix Pharmaceuticals Ltd is "NOVE."
What Stock Exchange Does Novelix Pharmaceuticals Ltd Trade On?
Novelix Pharmaceuticals Ltd is listed and trades on the BSE stock exchange.
Is Novelix Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Novelix Pharmaceuticals Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NOVE quote. (ISIN: INE314I01036)
BSE
Currency in INR
70.95
+1.95(+2.83%)
Delayed Data·
Fair Value
An estimate of a Novelix Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
69.00
70.95
52 wk Range
38.00
92.00
NOVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Novelix Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
69.0070.95
52 wk Range
38.0092.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NOVE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Novelix Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy
Earnings
Latest Release
May 29, 2026
EPS / Forecast
0.32 / --
Revenue / Forecast
251.94M / --
Compare NOVE to Peers and Sector
Metrics to compare | NOVE | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipNOVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 56.9x | 29.1x | −0.3x | |
PEG Ratio | 0.05 | 0.59 | 0.00 | |
Price/Book | 3.1x | 3.0x | 2.6x | |
Price / LTM Sales | 1.1x | 3.9x | 2.9x | |
Upside (Analyst Target) | - | 3.2% | 56.7% | |
Fair Value Upside | Unlock | 0.6% | 10.2% | Unlock |
Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Novelix Pharmaceuticals (NOVE) Stock Price Today?
The Novelix Pharmaceuticals stock price today is 70.95 INR.
What Stock Exchange Does Novelix Pharmaceuticals Trade On?
Novelix Pharmaceuticals is listed and trades on the Bombay Stock Exchange.
What Is the Stock Symbol for Novelix Pharmaceuticals?
The stock symbol for Novelix Pharmaceuticals is "NOVE."
What Is the Novelix Pharmaceuticals Market Cap?
As of today, Novelix Pharmaceuticals market cap is 1.50B INR.
What Is Novelix Pharmaceuticals's Earnings Per Share (TTM)?
The Novelix Pharmaceuticals EPS (TTM) is 1.21.
From a Technical Analysis Perspective, Is NOVE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Novelix Pharmaceuticals Stock Split?
Novelix Pharmaceuticals has split 2 times.
How Many Employees Does Novelix Pharmaceuticals Have?
Novelix Pharmaceuticals has 8 employees.
What is the current trading status of Novelix Pharmaceuticals (NOVE)?
As of Jul 30, 2026, Novelix Pharmaceuticals (NOVE) is trading at a price of 70.95 INR, with a previous close of 69.00 INR. The stock has fluctuated within a day range of 69.00 INR to 70.95 INR, while its 52-week range spans from 38.00 INR to 92.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.